Navigation Links
CNJ Enterprises: DePuy ASR Hip Implant Recall Large Contributor to Johnson & Johnson's $2.9 Bil Charge for 4th Quarter 2011
Date:2/27/2012

NEW YORK, Feb. 27, 2012 /PRNewswire/ -- Investors of Johnson & Johnson thought the $912mm charge in the 4th quarter of 2010 was a large number for the DePuy ASR Hip litigation; however the recent 4th quarter charge of $2.9bil partly attributed, according to CNJ Enterprises, to the DePuy Recall is 3 times last year's amount. 

This has led many product liability experts to believe that the DePuy litigation could top Avandia as the top "class action" litigation for 2011.  Industry experts are pointing towards the Sulzer Hip Recall of 2001 in which the Swiss Medical Device maker's recall placed in 31,000 patients settled for $1Bil.  The DePuy Recall is 3 times the size of Sulzer.  And with J&J executives recently deposed as to "what they knew", many believe that J&J's total exposure could top $3bil.  Apparently, this was a major factor in J&J's CEO, Bill Weldon, deciding to step down.    

One indication of the potential size of the settlement value for the DePuy victims is based on the lawsuit settlement funding industry's view of DePuy.   Legal-Bay LLC -a leader in lawsuit funding for both Avandia and DePuy- recently announced that they have secured $2.5mm in financing just for DePuy pre-settlement funding clients.    

Patty Kirby, Director of Client Relations at Legal-Bay commented, "Our research has indicated the average settlement amounts of the DePuy cases will top the Sulzer $200K average; cases in which the patient had the implant and revision surgery, could have values close to $1mm each.  Based on this, we have been funding our DePuy clients with advances up to $50K to pay bills until they get their ultimate settlement."

Legal-Bay was accurate in their forecast in the Avandia litigation as well, when they predicted GlaxoSmithKline would settle for over $2bil.  Recently, Glaxo settled 25,000 claims related to Avandia through mediation for what is being reported as close to $3bil.  However, victims will not get their money for months.        

Legal-Bay's website: lawsuitssettlementfunding.com and their toll free hotline 877.571.0405 have been busy taken lawsuit loan applications for the DePuy and Avandia litigation.  If history proves right this does not bode well for J&J on DePuy. 

Contact:
CNJ Enterprises- Julie Jansen, Cnjenterprisesllc@gmail.com
Legal-Bay- Patty Kirby,info@legal-bay.com, +1-877-571-0405

 

 

 


'/>"/>
SOURCE CNJ Enterprises LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Actress Jane Kaczmarek Teams Up With DePuy Orthopaedics to Launch Osteoarthritis Awareness and Education Program
2. DePuy ASR Hip Resurfacing System Failure Leads to Lawsuit, According to the Law Offices of John David Hart
3. Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart
4. Recalled DePuy Hip Implant Lawsuits Filed in Fort Worth, Texas
5. Bilateral DePuy Hip Implant Failures Lead to Lawsuit
6. Failure Rate of DePuy ASR XL Hip Implant Rising
7. Granbury, Texas Woman Files Suit for Failed DePuy Hip Device
8. Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman
9. DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas
10. DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
11. DePuy Recalled Hip Device Lawsuit Filed in East Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):